Caspase cleavage of viral proteins, another way for viruses to make the best of apoptosis

Cell Death and Disease

Volumn 3, Issue 3, 2012, Pages

  Richard, A ^a   Tulasne, D ^a  

^a UNIV LILLE   (France)

Author keywords

Apoptosis; Caspase cleavage; Viral subversion; Virus

Indexed keywords

CASPASE; VIRUS PROTEIN;

ADENOVIRUS; ALEUTIAN MINK DISEASE VIRUS; APOPTOSIS; ASTROVIRUS; CRIMEAN CONGO HEMORRHAGIC FEVER VIRUS; DOWN REGULATION; HEPATITIS C VIRUS; HUMAN; INFLUENZA VIRUS; MOLLUSCIPOXVIRUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; REVIEW; SARS CORONAVIRUS; TRANSMISSIBLE GASTROENTERITIS VIRUS; VESIVIRUS; VIRUS; VIRUS REPLICATION; WART VIRUS;

ANIMALS; APOPTOSIS; CASPASES; DNA VIRUS INFECTIONS; DNA VIRUSES; ENZYME ACTIVATION; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNE EVASION; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEOLYSIS; RNA VIRUS INFECTIONS; RNA VIRUSES; VIRAL PROTEINS; VIRUS REPLICATION;

EID: 84859365723     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2012.18     Document Type: Review

References (52)

1. Barber GN. Host defense, viruses and apoptosis. Cell Death Differ 2001; 8: 113-126. (Pubitemid 32201359)
2. Danthi P. Enter the kill zone: initiation of death signaling during virus entry. Virology 2011; 411: 316-324.
3. Labbe K, Saleh M. Cell death in the host response to infection. Cell Death Differ 2008; 15: 1339-1349.
4. Green DR, Ferguson T, Zitvogel L, Kroemer G. Immunogenic and tolerogenic cell death. Nat Rev Immunol 2009; 9: 353-363.
5. Kepp O, Senovilla L, Galluzzi L, Panaretakis T, Tesniere A, Schlemmer F et al. Viral subversion of immunogenic cell death. Cell Cycle 2009; 8: 860-869.
6. Galluzzi L, Brenner C, Morselli E, Touat Z, Kroemer G. Viral control of mitochondrial apoptosis. PLoS Pathog 2008; 4: e1000018.
7. Hay S, Kannourakis G. A time to kill: viral manipulation of the cell death program. J Gen Virol 2002; 83: 1547-1564. (Pubitemid 34716260)
8. Kaminskyy V, Zhivotovsky B. To kill or be killed: how viruses interact with the cell death machinery. J Intern Med 2010; 267: 473-482.
9. Li J, Yuan J. Caspases in apoptosis and beyond. Oncogene 2008; 27: 6194-6206.
10. Pop C, Salvesen GS. Human caspases: activation, specificity, and regulation. J Biol Chem 2009; 284: 21777-21781.
11. Best SM, Bloom ME. Caspase activation during virus infection: more than just the kiss of death? Virology 2004; 320: 191-194. (Pubitemid 38315146)
12. Clem RJ, Fechheimer M, Miller LK. Prevention of apoptosis by a baculovirus gene during infection of insect cells. Science 1991; 254: 1388-1390. (Pubitemid 21917477)
13. Bertin J, Mendrysa SM, LaCount DJ, Gaur S, Krebs JF, Armstrong RC et al. Apoptotic suppression by baculovirus P35 involves cleavage by and inhibition of a virus-induced CED-3/ICE-like protease. J Virol 1996; 70: 6251-6259. (Pubitemid 26266844)
14. Bump NJ, Hackett M, Hugunin M, Seshagiri S, Brady K, Chen P et al. Inhibition of ICE family proteases by baculovirus antiapoptotic protein p35. Science 1995; 269: 1885-1888.
15. Zhou Q, Krebs JF, Snipas SJ, Price A, Alnemri ES, Tomaselli KJ et al. Interaction of the baculovirus anti-apoptotic protein p35 with caspases. Specificity, kinetics, and characterization of the caspase/p35 complex. Biochemistry 1998; 37: 10757-10765.
16. Fisher AJ, Cruz W, Zoog SJ, Schneider CL, Friesen PD. Crystal structure of baculovirus P35: role of a novel reactive site loop in apoptotic caspase inhibition. EMBO J 1999; 18: 2031-2039. (Pubitemid 29179160)
17. Xu G, Cirilli M, Huang Y, Rich RL, Myszka DG, Wu H. Covalent inhibition revealed by the crystal structure of the caspase-8/p35 complex. Nature 2001; 410: 494-497. (Pubitemid 32240052)
18. Zoog SJ, Schiller JJ, Wetter JA, Chejanovsky N, Friesen PD. Baculovirus apoptotic suppressor P49 is a substrate inhibitor of initiator caspases resistant to P35 in vivo. EMBO J 2002; 21: 5130-5140.
19. Guy MP, Friesen PD. Reactive-site cleavage residues confer target specificity to baculovirus P49, a dimeric member of the P35 family of caspase inhibitors. J Virol 2008; 82: 7504-7514. (Pubitemid 352031218)
20. Yan F, Xia D, Lv S, Qi Y, Xu H. Functional analysis of the orf390 gene of the white spot syndrome virus. Virus Res 2010; 151: 39-44.
21. Leu JH, Chen LL, Lin YR, Kou GH, Lo CF. Molecular mechanism of the interactions between white spot syndrome virus anti-apoptosis protein AAP-1 (WSSV449) and shrimp effector caspase. Dev Comp Immunol 2010; 34: 1068-1074.
22. Best SM, Wolfinbarger JB, Bloom ME. Caspase activation is required for permissive replication of Aleutian mink disease parvovirus in vitro. Virology 2002; 292: 224-234. (Pubitemid 34920542)
23. Best SM, Shelton JF, Pompey JM, Wolfinbarger JB, Bloom ME. Caspase cleavage of the nonstructural protein NS1 mediates replication of Aleutian mink disease parvovirus. J Virol 2003; 77: 5305-5312. (Pubitemid 36460944)
24. Moody CA, Laimins LA. Human papillomaviruses activate the ATM DNA damage pathway for viral genome amplification upon differentiation. PLoS Pathog 2009; 5: e1000605.
25. Moody CA, Fradet-Turcotte A, Archambault J, Laimins LA. Human papillomaviruses activate caspases upon epithelial differentiation to induce viral genome amplification. Proc Natl Acad Sci USA 2007; 104: 19541-19546.
26. Fei JW, de Villiers EM. Degradation of HPV20E6 by p53: delta Np63 alpha and mutant p53R248W protect the wild type p53 mediated caspase-degradation. Int J Cancer 2008; 123: 108-116.
27. Banos-Lara Mdel R, Mendez E. Role of individual caspases induced by astrovirus on the processing of its structural protein and its release from the cell through a non-lytic mechanism. Virology 2010; 401: 322-332.
28. Mendez E, Salas-Ocampo E, Arias CF. Caspases mediate processing of the capsid precursor and cell release of human astroviruses. J Virol 2004; 78: 8601-8608. (Pubitemid 39025126)
29. Diemer C, Schneider M, Seebach J, Quaas J, Frosner G, Schatzl HM et al. Cell type-specific cleavage of nucleocapsid protein by effector caspases during SARS coronavirus infection. J Mol Biol 2008; 376: 23-34.
30. Majerciak V, Kruhlak M, Dagur PK, McCoy Jr JP, Zheng ZM. Caspase-7 cleavage of Kaposi sarcoma-associated herpesvirus ORF57 confers a cellular function against viral lytic gene expression. J Biol Chem 2010; 285: 11297-11307.
31. Cheng F, Chen AY, Best SM, Bloom ME, Pintel D, Qiu J. The capsid proteins of Aleutian mink disease virus activate caspases and are specifically cleaved during infection. J Virol 2010; 84: 2687-2696.
32. Karlberg H, Tan YJ, Mirazimi A. Induction of caspase activation and cleavage of the viral nucleocapsid protein in different cell types during Crimean-Congo hemorrhagic fever virus infection. J Biol Chem 2011; 286: 3227-3234.
33. Zhirnov O, Bukrinskaya AG. Nucleoproteins of animal influenza viruses, in contrast to those of human strains, are not cleaved in infected cells. J Gen Virol 1984; 65 (Part 6): 1127-1134. (Pubitemid 14106113)
34. Zhirnov OP, Konakova TE, Garten W, Klenk H. Caspase-dependent N-terminal cleavage of influenza virus nucleocapsid protein in infected cells. J Virol 1999; 73: 10158-10163.
35. Lipatov AS, Yen HL, Salomon R, Ozaki H, Hoffmann E, Webster RG. The role of the N-terminal caspase cleavage site in the nucleoprotein of influenza A virus in vitro and in vivo. Arch Virol 2008; 153: 427-434.
36. Zhirnov OP, Konakova TE, Wolff T, Klenk HD. NS1 protein of influenza A virus down-regulates apoptosis. J Virol 2002; 76: 1617-1625. (Pubitemid 34094608)
37. Zhirnov OP, Syrtzev VV. Influenza virus pathogenicity is determined by caspase cleavage motifs located in the viral proteins. J Mol Genet Med 2009; 3: 124-132.
38. Zhirnov OP, Klenk HD. Alterations in caspase cleavage motifs of NP and M2 proteins attenuate virulence of a highly pathogenic avian influenza virus. Virology 2009; 394: 57-63.
39. Goh PY, Tan YJ, Lim SP, Lim SG, Tan YH, Hong WJ. The hepatitis C virus core protein interacts with NS5A and activates its caspase-mediated proteolytic cleavage. Virology 2001; 290: 224-236. (Pubitemid 33141224)
40. Kalamvoki M, Georgopoulou U, Mavromara P. The NS5A protein of the hepatitis C virus genotype 1a is cleaved by caspases to produce C-terminal-truncated forms of the protein that reside mainly in the cytosol. J Biol Chem 2006; 281: 13449-13462. (Pubitemid 43855257)
41. Kalamvoki M, Mavromara P. Calcium-dependent calpain proteases are implicated in processing of the hepatitis C virus NS5A protein. J Virol 2004; 78: 11865-11878. (Pubitemid 39390773)
42. Satoh S, Hirota M, Noguchi T, Hijikata M, Handa H, Shimotohno K. Cleavage of hepatitis C virus nonstructural protein 5A by a caspase-like protease(s) in mammalian cells. Virology 2000; 270: 476-487. (Pubitemid 30333694)
43. Eleouet JF, Chilmonczyk S, Besnardeau L, Laude H. Transmissible gastroenteritis coronavirus induces programmed cell death in infected cells through a caspase-dependent pathway. J Virol 1998; 72: 4918-4924. (Pubitemid 28215670)
44. Eleouet JF, Slee EA, Saurini F, Castagne N, Poncet D, Garrido C et al. The viral nucleocapsid protein of transmissible gastroenteritis coronavirus (TGEV) is cleaved by caspase-6 and -7 during TGEV-induced apoptosis. J Virol 2000; 74: 3975-3983. (Pubitemid 30214402)
45. Al-Molawi N, Beardmore VA, Carter MJ, Kass GE, Roberts LO. Caspase-mediated cleavage of the feline calicivirus capsid protein. J Gen Virol 2003; 84: 1237-1244. (Pubitemid 36592616)
46. Roberts LO, Al-Molawi N, Carter MJ, Kass GE. Apoptosis in cultured cells infected with feline calicivirus. Ann NY Acad Sci 2003; 1010: 587-590. (Pubitemid 38265051)
47. Grand RJ, Schmeiser K, Gordon EM, Zhang X, Gallimore PH, Turnell AS. Caspase-mediated cleavage of adenovirus early region 1A proteins. Virology 2002; 301: 255-271. (Pubitemid 35176550)
48. Shisler JL, Moss B. Molluscum contagiosum virus inhibitors of apoptosis: the MC159 v-FLIP protein blocks Fas-induced activation of procaspases and degradation of the related MC160 protein. Virology 2001; 282: 14-25. (Pubitemid 32881771)
49. Munger J, Hagglund R, Roizman B. Infected cell protein no. 22 is subject to proteolytic cleavage by caspases activated by a mutant that induces apoptosis. Virology 2003; 305: 364-370.
50. Barkett M, Dooher JE, Lemonnier L, Simmons L, Scarpati JN, Wang Y et al. Three mutations in v-Rel render it resistant to cleavage by cell-death protease caspase-3. Biochim Biophys Acta 2001; 1526: 25-36. (Pubitemid 32245768)
51. Sanjuan R, Nebot MR, Chirico N, Mansky LM, Belshaw R. Viral mutation rates. J Virol 2010; 84: 9733-9748.
52. Wang L, Zhi B, Wu W, Zhang X. Requirement for shrimp caspase in apoptosis against virus infection. Dev Comp Immunol 2008; 32: 706-715.